Supplementary Materials

The PDF file includes:

  • Fig. S1. Cutaneous cytokine expression and immune infiltrate follow hair eruption in EGFRΔep mice.
  • Fig. S2. Hair eruption initiates barrier defect and inflammation.
  • Fig. S3. The bacterial composition affects the phenotype of EGFRΔep and of erlotinib-treated mice.
  • Fig. S4. Transgenic K5-SOS expression reduces inflammation in EGFRΔep mice.
  • Fig. S5. The atopic signatures of EGFRΔep mice can be distinguished in bacteria-dependent and bacteria-independent settings.
  • Fig. S6. Patients with SCC treated with cetuximab display reduced filaggrin expression, mixed immune infiltrate, and bacterial colonization.
  • Fig. S7. Prophylactic, but not reactive, FGF7 prevents inflammation in EGFRΔep mice without inducing papilloma formation.
  • Table S1. Resources.

[Download PDF]

Other Supplementary Material for this manuscript includes the following: